Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;45(3):504-511.
doi: 10.1016/j.bj.2021.06.001. Epub 2021 Jun 9.

Implementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome

Affiliations

Implementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome

Yuan-Ming Yeh et al. Biomed J. 2022 Jun.

Abstract

Background: Fecal microbiota transplantation (FMT) has been shown to highly effective in the treatment of recurrent or refractory Clostridioides difficile infection (rCDI) in many countries of the world. Not until 2018, Ministry of Health and Welfare, Taiwan approved the application of FMT for rCDI under a special law. The study reported the first implementation of the technology in the medical center in Taiwan and the preliminary outcome.

Methods: FMT was used to treat patients with rCDI in Chang Gung Memorial Hospital. FMT was delivered by gastroenterologists using colonoscope. Strict donor screening was performed according to the guidelines. We followed up the clinical course of patients after FMT. 16S rRNA sequencing of fecal samples for donor, and also recipient before and after FMT was carried out.

Results: From September 2018 to June 2020, 39 patients with rCDI received FMT, with a successful rate of 89.7%. Two patients died due to causes unrelated to FMT, and two other cases showed no clinical improvement after the procedure. High school and college students showed the best pass rate during donor screening. The presence of multi-drug resistant pathogen was the most common cause for screening failure. We demonstrated in a case the use of rRNA sequencing as a biomarker indicating for the improvement of dysbiosis in a patient after FMT.

Conclusions: FMT was successfully implemented in a medical center in Taiwan and showed a comparable successful rate in treating rCDI, compared to other countries. Safety remains the most important issue when applying FMT in the clinical setting.

Keywords: 16S rRNA sequencing; Clostridioides difficile infection; Donor screening; Fecal microbiota transplantation; Outcome.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest The authors have no financial or ethical conflicts of interest to report.

Figures

Fig. 1
Fig. 1
The outline of FMT transplant preparation. Schematic diagram of the preparation process is from (A) 50 ± 10 g stool homogenized with 250 ml sterile normal saline; (B) filtration by sterile mesh; (C) centrifugation 1500×g/5mins to remove the suspend; (D) resuspending with fresh sterile normal saline; (E) ready-to-use FMT material; (F) adding 10% v/v glycerol and storage at −80 °C; or (G) administration of FMT material by colonoscopy.
Fig. 2
Fig. 2
A timeline for fecal microbiota transplantation in a patient. Abbreviations: CD: C. difficile; CDI: C. difficile infection; GI: Gastroenterology; OPD: outpatient clinic; FMT: fecal microbiota transplantation. (+) indicates a positive testing result, and (−) indicates a negative result.
Fig. 3
Fig. 3
Gut microbiota analysis before and after FMT. (A) Upper: richness of microbiota analysis was by Shannon index (alpha diversity); Lower: relative abundance at phyla level. (B) PCoA of weighted UniFrac for beta diversity.

References

    1. Zhang F., Luo W., Shi Y., Fan Z., Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol. 2012;107:1755–1756. - PubMed
    1. Zhang F., Cui B., He X., Nie Y., Wu K., Fan D., et al. Microbiota transplantation: concept, methodology and strategy for its modernization. Protein Cell. 2018;9:462–473. - PMC - PubMed
    1. Debast S.B., Bauer M.P., Kuijper E.J., European Society of Clinical Microbiology and Infectious Diseases European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20 Suppl 2:1–26. - PubMed
    1. Sokol H., Galperine T., Kapel N., Bourlioux P., Seksik P., Barbut F., et al. Faecal microbiota transplantation in recurrent Clostridium difficile infection: recommendations from the French Group of Faecal microbiota Transplantation. Dig Liver Dis. 2016;48:242–247. - PubMed
    1. Konig J., Siebenhaar A., Hogenauer C., Arkkila P., Nieuwdorp M., Noren T., et al. Consensus report: faecal microbiota transfer - clinical applications and procedures. Aliment Pharmacol Ther. 2017;45:222–239. - PMC - PubMed

Substances

LinkOut - more resources